Publication | Closed Access

First-Line Gefitinib in Patients Aged 75 or Older With Advanced Non–Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: NEJ 003 Study

Patients Aged 75MedicineFirst-line GefitinibPathologyCancer GenomicsCancer TreatmentCancer GeneticsOncologyRadiation OncologyLung CancerMolecular OncologyNej 003